DIABINESE Drug Patent Profile
✉ Email this page to a colleague
When do Diabinese patents expire, and what generic alternatives are available?
Diabinese is a drug marketed by Pfizer and is included in one NDA.
The generic ingredient in DIABINESE is chlorpropamide. There are eleven drug master file entries for this compound. Additional details are available on the chlorpropamide profile page.
Summary for DIABINESE
US Patents: | 0 |
Applicants: | 1 |
NDAs: | 1 |
Raw Ingredient (Bulk) Api Vendors: | 112 |
Clinical Trials: | 1 |
Patent Applications: | 3,609 |
Formulation / Manufacturing: | see details |
DailyMed Link: | DIABINESE at DailyMed |
Recent Clinical Trials for DIABINESE
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Novartis | Phase 2 |
Anatomical Therapeutic Chemical (ATC) Classes for DIABINESE
US Patents and Regulatory Information for DIABINESE
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Pfizer | DIABINESE | chlorpropamide | TABLET;ORAL | 011641-003 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Pfizer | DIABINESE | chlorpropamide | TABLET;ORAL | 011641-006 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |